Tracking antibiotic resistance in patients with cirrhosis and infections

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study monitors the prevalence of antibiotic resistance in patients suffering from cirrhosis who develop bacterial infections. Given that cirrhosis patients are at a heightened risk for serious infections, the study aims to gather data on the types of bacteria causing these infections and their resistance patterns. The findings will help inform empirical antibiotic treatment guidelines specifically tailored for the Latin American region, where current guidelines are lacking. By understanding the local epidemiology of infections, the study seeks to improve patient outcomes through timely and appropriate antibiotic therapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Episodes of culture-confirmed bacterial infections
* Patients diagnosed with cirrhosis
* Infections diagnosed either at the time of hospital admission or during hospitalization

Exclusion Criteria:

* History of solid organ or hematopoietic stem cell transplantation
* Declined to participate in the study

Where it's running

• Hospital Italiano de Buenos Aires
  Buenos Aires, Buenos Aires F.D., Argentina Recruiting

Study contacts

• Study coordinator: Sebastián M Marciano, Principal Investigator.
• Email: sebastian.marciano@hospitalitaliano.org.ar
• Phone: 54 11 49590200

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endovascular treatment outcomes after portal hypertension–related GI bleeding in cirrhosis

  This study tests how well endovascular procedures for portal hypertension–related GI bleeding work in adults with cirrhosis, and what factors predict outcomes.

  Recruiting University Medical Center Ho Chi Minh City (UMC) · Ho Chi Minh City · NCT07918378

• EUS-guided coil and glue vs glue injection for bleeding gastric varices in cirrhosis

  This trial tests whether using endoscopic ultrasound to guide coils plus glue works better than glue alone for stopping bleeding from gastric varices in adults with cirrhosis.

  Recruiting Medanta, The Medicity, India · Orlando, Florida and 1 other locations · NCT07855913

• CTX-187 first-in-human test in healthy people and people with chronic bronchiectasis and Pseudomonas infection

  This study tests CTX-187 to see if it is safe and tolerable when given as IV infusions to healthy adults and adults with chronic bronchiectasis and Pseudomonas aeruginosa infection.

  Recruiting Phase 1 Centauri Therapeutics Limited · Groningen · NCT07708116

• Personalized beta-lactam dosing in cirrhosis patients with bacterial infections

  This study tests whether tailoring beta-lactam dosing based on patient liver disease and drug levels can help people with cirrhosis and bacterial infections.

  Recruiting The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu · NCT07612163

• Vaginitis Diagnostic Algorithm Pilot Using Nanopath and Other Tests

  This study tests a new Nanopath vaginal test to see if it correctly detects vaginitis-causing pathogens in up to 1,000 people with vaginitis symptoms.

  Recruiting at 2 sites Nanopath, Inc · North Miami, Florida and 1 other locations · NCT07607470

• 4D-Flow MRI to see portal hypertension and TIPS outcomes in cirrhosis

  This study tests a noninvasive 4D-Flow MRI method to see if it can safely and reliably reflect portal hypertension and predict outcomes for people with cirrhosis, including those needing a TIPS procedure.

  Recruiting at 2 sites Assistance Publique - Hôpitaux de Paris · Paris and 1 other locations · NCT07554183

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.